Epidemiology and management of hyperlipidemia.
Karr S.
Am J Manag Care. 2017 Jun;23(9 Suppl):S139-S148.
Lipid metabolism and hyperlipidemia in dogs.
Xenoulis PG, Steiner JM.
Vet J. 2010 Jan;183(1):12-21. doi: 10.1016/j.tvjl.2008.10.011. Epub 2009 Jan 23.
Postprandial Hyperlipidemia: Its Pathophysiology, Diagnosis, Atherogenesis, and Treatments.
Yanai H, Adachi H, Hakoshima M, Katsuyama H.
Int J Mol Sci. 2023 Sep 11;24(18):13942. doi: 10.3390/ijms241813942.
Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia.
Gill PK, Dron JS, Berberich AJ, Wang J, McIntyre AD, Cao H, Hegele RA.
J Clin Lipidol. 2021 Jan-Feb;15(1):79-87. doi: 10.1016/j.jacl.2020.11.006. Epub 2020 Nov 24.
Hyperlipidemia and Cardiovascular Disease in People with Type 1 Diabetes: Review of Current Guidelines and Evidence.
Karmali R, Sipko J, Majid M, Bruemmer D.
Curr Cardiol Rep. 2023 May;25(5):435-442. doi: 10.1007/s11886-023-01866-x. Epub 2023 Apr 13.
Lipoprotein glomerulopathy.
Tsimihodimos V, Elisaf M.
Curr Opin Lipidol. 2011 Aug;22(4):262-9. doi: 10.1097/MOL.0b013e328345ebb0.
Oleoylethanolamide alleviates hyperlipidaemia-mediated vascular calcification via attenuating mitochondrial DNA stress triggered autophagy-dependent ferroptosis by activating PPARalpha.
Chen Z, Sun X, Li X, Liu N.
Biochem Pharmacol. 2023 Feb;208:115379. doi: 10.1016/j.bcp.2022.115379. Epub 2022 Dec 13.
Hypertriglyceridaemia: an update.
Wierzbicki AS, Kim EJ, Esan O, Ramachandran R.
J Clin Pathol. 2022 Dec;75(12):798-806. doi: 10.1136/jclinpath-2021-207719. Epub 2022 Jun 16.
Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
Duntas L, Kolovou G.
Future Cardiol. 2011 Mar;7(2):137-44. doi: 10.2217/fca.10.126.
Hyperlipidemia.
Sloan RW.
Am Fam Physician. 1983 Sep;28(3):171-82.
